ProfileGDS4718 / 224960_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 96% 90% 96% 96% 89% 88% 96% 94% 96% 96% 94% 95% 89% 94% 96% 96% 92% 92% 88% 97% 96% 96% 96% 96% 92% 94% 89% 95% 90% 94% 89% 95% 97% 90% 91% 91% 94% 95% 88% 95% 91% 93% 90% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.952697
GSM549102patient 115, normal, homogenized [OPG study]10.586396
GSM549104patient 119, normal, homogenized [OPG study]9.1878990
GSM549108patient 138, normal, homogenized [OPG study]10.565896
GSM549119patient 077, normal, homogenized [OPG study]10.586196
GSM549133patient 032, cancer, homogenized [OPG study]9.2113889
GSM549139patient 042, cancer, homogenized [OPG study]8.8654988
GSM549099patient 107, normal, homogenized [OPG study]10.556496
GSM549109patient 139, normal, homogenized [OPG study]10.028694
GSM549110patient 046, normal, homogenized [OPG study]10.811896
GSM549114patient 063, normal, homogenized [OPG study]10.921796
GSM549122patient 082, normal, homogenized [OPG study]10.02994
GSM549134patient 033, cancer, homogenized [OPG study]10.240595
GSM549136patient 036, cancer, homogenized [OPG study]9.1144489
GSM549140patient 044, cancer, homogenized [OPG study]9.9582594
GSM549111patient 047, normal, homogenized [OPG study]10.710996
GSM549113patient 057, normal, homogenized [OPG study]10.666996
GSM549132patient 031, cancer, homogenized [OPG study]9.5146692
GSM549137patient 038, cancer, homogenized [OPG study]9.4145692
GSM549142patient 047, cancer, homogenized [OPG study]8.4104988
GSM549100patient 110, normal, homogenized [OPG study]11.015397
GSM549107patient 135, normal, homogenized [OPG study]10.811996
GSM549115patient 068, normal, homogenized [OPG study]10.884396
GSM549116patient 072, normal, homogenized [OPG study]10.512596
GSM549120patient 078, normal, homogenized [OPG study]10.700896
GSM549131patient 030, cancer, homogenized [OPG study]9.6371392
GSM549118patient 074, normal, homogenized [OPG study]10.095694
GSM549129patient 027, cancer, homogenized [OPG study]8.9585889
GSM549123patient 088, normal, homogenized [OPG study]10.456995
GSM549124patient 006, cancer, homogenized [OPG study]8.9746990
GSM549126patient 015, cancer, homogenized [OPG study]9.9499794
GSM549128patient 025, cancer, homogenized [OPG study]9.0789789
GSM549103patient 117, normal, homogenized [OPG study]10.274995
GSM549117patient 073, normal, homogenized [OPG study]11.360397
GSM549138patient 041, cancer, homogenized [OPG study]9.1273290
GSM549141patient 045, cancer, homogenized [OPG study]9.3771891
GSM549130patient 028, cancer, homogenized [OPG study]9.3163691
GSM549101patient 111, normal, homogenized [OPG study]10.023894
GSM549105patient 128, normal, homogenized [OPG study]10.209395
GSM549106patient 134, normal, homogenized [OPG study]9.0293788
GSM549112patient 048, normal, homogenized [OPG study]10.474295
GSM549125patient 011, cancer, homogenized [OPG study]9.3268891
GSM549127patient 024, cancer, homogenized [OPG study]9.5789993
GSM549135patient 035, cancer, homogenized [OPG study]9.2158390